인문학
사회과학
자연과학
공학
의약학
농수해양학
예술체육학
복합학
지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
초록·키워드
Abstract Background Cardiac myxoma constitutes the most prevalent primary heart tumour, often necessitating surgical resection to prevent complications. While median sternotomy is the standard approach, it is associated with significant morbidity. Robotic-assisted myxoma excision (RA-ME) has emerged as a minimally invasive alternative, but comparative data on their outcomes remain limited. Our meta-analysis aimed to compare postoperative outcomes of RA-ME versus conventional median sternotomy myxoma excision (MS-ME). Methods We systematically searched MEDLINE, Scopus, and Cochrane Library, focusing on studies that compared RA-ME and MS-ME. Pooled odds ratios (OR) and mean differences (MD) with 95% confidence intervals (CI) were calculated using RevMan 8.13.0. Results Seven studies comprising 447 patients, with 180 (40.3%) undergoing RA-ME, were included. RA-ME was associated with significantly longer cardiopulmonary bypass times [MD 23.0 min; 95% CI 11.1 to 35.00; p = 0.0001] and aortic cross-clamp times [MD 11.4 min; 95% CI 4.6 to 18.2; p = 0.001]. However, it demonstrated reduced hospital stay [MD − 2.00 days; 95% CI − 2.6 to − 1.4; p < 0.001], ICU stay [MD − 0.3 days; 95% CI − 0.5 to − 0.01; p = 0.04], blood loss [MD − 115.2 mL; 95% CI − 230.4 to − 0.02; p = 0.05], and blood transfusion requirements [OR 0.4; 95% CI 0.2 to 0.8; p = 0.01]. Other outcomes, including mechanical ventilation time, surgical re-exploration, arrhythmias, pneumonia, and surgical wound infections, were comparable. Conclusions RA-ME may be a safe and effective alternative to MS-ME, offering improved recovery metrics with no compromise in safety despite longer operative times. However, high-quality prospective trials are needed for further validation. Trial registration PROSPERO CRD42025633712.
인공지능 문자 인식 모델을 통해 추출된 텍스트로, 일부 오타나 오류가 포함될 수 있으나 지속적으로 개선 중입니다.
오류를 발견하셨다면 해당 부분을 드래그한 후 ' 를 통해 신고해주세요.
오류를 발견하셨다면 해당 부분을 드래그한 후 ' 를 통해 신고해주세요.